HOming in on arteriovenous fistula survival

Kidney International

Volumn 74, Issue 1, 2008, Pages 9-11

  Durante, W ^a,d   Lin, C C ^b,c  

^a UNIVERSITY OF MISSOURI   (United States)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIVERDIN; CARBON MONOXIDE; FERRITIN; HEAT SHOCK PROTEIN; HEME OXYGENASE 1; IRON;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTERIOVENOUS FISTULA; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG POTENCY; ENDOTHELIUM CELL; ENZYME ANALYSIS; FIBROSIS; GENE DELETION; HEMODIALYSIS; HEMODYNAMIC MONITORING; MOUSE; NONHUMAN; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; THROMBOSIS PREVENTION; TREATMENT FAILURE; VASCULAR ACCESS; VASODILATATION;

EID: 45249090575     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.127     Document Type: Note

References (10)

1. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996; 7: 523-535.
2. Roy-Chaudhury P, Lee TC. Vascular stenosis: biology and interventions. Curr Opin Nephrol Hypertens 2007; 16: 516-522.
3. Durante W, Johnson RK, Johnson RA. Role of carbon monoxide in cardiovascular function. J Cell Mol Med 2006; 10: 672-686.
4. Lin C-C, Yang W-C, Lin SJ et al. Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. Kidney Int 2006; 69: 165-172.
5. Juncos JP, Tracz MJ, Croatt AJ et al. Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse. Kidney Int 2008; 73: 47-51.
6. Castier Y, Lehoux S, Hu Y et al. Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model. Kidney Int 2006; 70: 315-320.
7. Wagner C, Durante W, Christodoulides N et al. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest 1997; 100: 589-596.
8. Ollinger R, Bilban M, Erat A et al. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 2005; 112: 1030-1039.
9. Lin C-C, Chang CF, Lai MY et al. Far infrared therapy: a novel treatment improving access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients. J Am Soc Nephrol 2007; 18: 985-992.
10. Lin C-C, Liu X-M, Peyton K et al. Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1. Arterioscler Thromb Vasc Biol 2008; 28: 739-745.